Drugs

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

3 monthes ago   |   By Xconomy

A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual version of the ASCO conference, the cancer field's largest, kicks off, with oncologists and others tuning in from throughout the country and around the world to check out the latest in cancer research. ASCO 2020 won't be the Windy City gathering it usually is, but drug and diagnostics developers are still raring to share fresh data from their efforts in cancer immunotherapy, targeted treatments, and early-stage screening methods during the course of the...
Read more ...

 

Cardiff Oncology Data Continues to Demonstrate Efficacy of Onvansertib in Patients with KRAS-Mutated Metastatic Colorectal Cancer Presented at ASCO

Cardiff Oncology Data Continues to Demonstrate Efficacy of Onvansertib in Patients with KRAS-Mutated Metastatic Colorectal Cancer Presented at ASCO

3 monthes ago   |   By San Diego Biotechnology

Positive data presented at ASCO follows announcement of Fast Track Designation granted by the FDA for onvansertib in second-line treatment of patients with KRAS-mutated mCRC- 89% overall clinical benefit achieved - objective response rate of......
Read more ...

 

Data Affirming Biocept's Target Selector Platform Identifies Cancer Mutations in Cerebrospinal Fluid Presented at ASCO 2020 Virtual Scientific Program

3 monthes ago   |   By San Diego Biotechnology

Target Selector platform shown to be potentially more sensitive than standard-of-care cytology in detecting mutations of brain metastases in cerebrospinal fluid
SAN DIEGO, May 29, 2020 /PRNewswire/ - Biocept, Inc. , a leading comme......
Read more ...

 

Gossamer Bio Announces Early Encouraging Safety and Biomarker Data from Phase 1/2 Study of GB1275 at American Society of Clinical Oncology 2020 Virtual Scientific Program

3 monthes ago   |   By San Diego Biotechnology

SAN DIEGO--- $GOSS-Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and onco......
Read more ...

 


Search by Tags

   Drugs      Drug      Research      Clinical      Diagnostics      Cancer      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Europe blog main      Europe top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      AbCellera      AI      Allievex      Alvaxa Biosciences      Alzheimer's disease      American Society of Clinical Oncology      Amivas      Andreessen Horowitz      Antibody Drugs      Arcus Biosciences      ASCO      Assembly Bio      Avidity Biosciences      BioMarin Pharmaceutical      Biotech      Bristol-myers Squibb      Burning Rock Biotech      Clinical trials      Contraception      Coronavirus      COVID-19      David Loew      Deerfield Management      Evofem      Evofem Biosciences      FDA      Financing      Fred Hutchinson Cancer Research Center      Funding      Generation Bio      Gilead Sciences      Ginkgo BioWorks      GlaxoSmithKline      IAVI      Immunomedics      Immunotherapy      Incubator      Insitro      Intercept Pharmaceuticals      IPO      Ipsen      Life Sciences      Liver Diseases      Machine Learning      Malaria      Merck      Monte Rosa Therapeutics      NASH      NovaVax      PhaseBio Pharmaceuticals      Praha Vaccines      Q32 Bio      R&D      Regeneron Pharmaceuticals      Repare Therapeutics      Ridgeback Biotherapeutics      Sanofi      Sensei Biotherapeutics      Shionogi      Sierra Oncology      Startups      Stem Cells      Tetra Therapeutics      Themis      University of Michigan      Variant Bio      Vaxcyte      Venture Capital      Versant Ventures      ViaCyte      Vir Biotechnology      Women's health      News      PR Newswire      Syndication      Biotechnology      Clinical Trials      Medical Discoveries      Health Care      Hospitals      Medical      Pharmaceuticals      Brain      Surveys      Polls & Research      Immunology      Therapeutics  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Tau-Targeting Alzheimer's Drug from AC Immune, Roche Fails in Phase 2

Tau-Targeting Alzheimer's Drug from AC Immune, Roche Fails in Phase 2

An Alzheimer's disease drug from partners AC Immune and Roche has failed a mid-stage clinical trial, adding another compound to the list of experimental therapies that have... Read more ...

Athira CEO Kawas: Alzheimer's Drug Aims for “Recovery of Brain Function”

Athira CEO Kawas: Alzheimer's Drug Aims for “Recovery of Brain Function”

The key to Athira Pharma's approach to Alzheimer's disease is already inside each of us: a repair mechanism that can regenerate damaged neurons. What's needed to begin the... Read more ...

Gene Therapy Firms Seek Clarity on FDA Exclusivity, Orphan Designations

Gene Therapy Firms Seek Clarity on FDA Exclusivity, Orphan Designations

Gene therapy product developers are seeking more clarity from the US Food and Drug Administration on when viral vectors from the same class will be considered sufficiently... Read more ...

Checkmate, Chromosome 8: The First End-to-End Sequence of a Human Autosome

Checkmate, Chromosome 8: The First End-to-End Sequence of a Human Autosome

Even in the field of genomics where new breakthroughs occur every few months, completion of the first-ever fully sequenced human autosome is a momentous achievement. Highly... Read more ...

Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal

Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal

Grail is set to be acquired for $8 billion by Illumina, the gene sequencing giant that formed the cancer diagnostics developer and spun it out as a separate company four years... Read more ...

Xconomy Awards On-Demand ‘Meet the Finalists' Webcast Series Continues This Week

Xconomy Awards On-Demand ‘Meet the Finalists' Webcast Series Continues This Week

The 2020 National Xconomy Awards complimentary two-week, 11-part, on-demand Meet the Finalists daily webcast series continues this Tuesday and Wednesday at 11 a.m. ET... Read more ...

Engineering Graduate Students Honored as Siebel Scholars

Read more ...

Unraveling the genome in 3-D space

Proper folding of extremely long chromosomal DNA molecules is crucial for the correct functioning of the cell. Scientists from the Gerlich lab at IMBA-Institute of Molecular... Read more ...

Patented 'molecular heaters' to increase crop yield

Researchers at the University of Amsterdam have developed a novel class of molecules capable of raising the temperature of plants. Application of such molecular heaters allows... Read more ...

A class of low‐cost alternatives to kifunensine for increasing high mannose...

Abstract N‐linked glycosylation of therapeutic monoclonal antibodies is an important product quality attribute for drug safety and efficacy. An increase in the percent of high... Read more ...